Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects

Jorge Brieva, Adam Wanner

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

The purpose of the present study was to determine the responsiveness of airway vascular smooth muscle (AVSM) as assessed by airway mucosal blood flow (Qaw) to inhaled methoxamine (α1-agonist; 0.6-2.3 mg) and albuterol (β2-agonist; 0.2-1.2 mg) in healthy [n = 11; forced expiratory volume in 1 s, 92 ± 4 (SE) % of predicted] and asthmatic (n = 11, mean forced expiratory volume in 1 s, 81 ± 5%) adults. Mean baseline values for Qaw were 43.8 ± 0.7 and 54.3 ± 0.8 μl·min-1·ml-1 of anatomic dead space in healthy and asthmatic subjects, respectively (P < 0.05). After methoxamine inhalation, the maximal mean change in Qaw was -13.5 ± 1.0 μl·min-1·ml-1 in asthmatic and -7.1 ± 2.1 μl·min-1·ml-1 in healthy subjects (P < 0.05). After albuterol, the mean maximal change in Qaw was 3.0 ± 0.8 μl·min-1·ml-1 in asthmatic and 14.0 ± 1.1 μl·min-1·ml-1 in healthy subjects (P < 0.05). These results demonstrate that the contractile response of AVSM to α1-adrenoceptor activation is enhanced and the dilator response of AVSM to β2-adrenoceptor activation is blunted in asthmatic subjects.

Original languageEnglish
Pages (from-to)665-669
Number of pages5
JournalJournal of Applied Physiology
Volume90
Issue number2
StatePublished - Feb 15 2001

Fingerprint

Vascular Smooth Muscle
Adrenergic Agents
Methoxamine
Healthy Volunteers
Albuterol
Forced Expiratory Volume
Adrenergic Receptors
Inhalation

Keywords

  • Adrenergic agonists
  • Asthma
  • Bronchial blood flow

ASJC Scopus subject areas

  • Physiology
  • Endocrinology
  • Orthopedics and Sports Medicine
  • Physical Therapy, Sports Therapy and Rehabilitation

Cite this

Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects. / Brieva, Jorge; Wanner, Adam.

In: Journal of Applied Physiology, Vol. 90, No. 2, 15.02.2001, p. 665-669.

Research output: Contribution to journalArticle

@article{6e6d3c3a9234421b92d544b2add65e19,
title = "Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects",
abstract = "The purpose of the present study was to determine the responsiveness of airway vascular smooth muscle (AVSM) as assessed by airway mucosal blood flow (Qaw) to inhaled methoxamine (α1-agonist; 0.6-2.3 mg) and albuterol (β2-agonist; 0.2-1.2 mg) in healthy [n = 11; forced expiratory volume in 1 s, 92 ± 4 (SE) {\%} of predicted] and asthmatic (n = 11, mean forced expiratory volume in 1 s, 81 ± 5{\%}) adults. Mean baseline values for Qaw were 43.8 ± 0.7 and 54.3 ± 0.8 μl·min-1·ml-1 of anatomic dead space in healthy and asthmatic subjects, respectively (P < 0.05). After methoxamine inhalation, the maximal mean change in Qaw was -13.5 ± 1.0 μl·min-1·ml-1 in asthmatic and -7.1 ± 2.1 μl·min-1·ml-1 in healthy subjects (P < 0.05). After albuterol, the mean maximal change in Qaw was 3.0 ± 0.8 μl·min-1·ml-1 in asthmatic and 14.0 ± 1.1 μl·min-1·ml-1 in healthy subjects (P < 0.05). These results demonstrate that the contractile response of AVSM to α1-adrenoceptor activation is enhanced and the dilator response of AVSM to β2-adrenoceptor activation is blunted in asthmatic subjects.",
keywords = "Adrenergic agonists, Asthma, Bronchial blood flow",
author = "Jorge Brieva and Adam Wanner",
year = "2001",
month = "2",
day = "15",
language = "English",
volume = "90",
pages = "665--669",
journal = "Journal of Applied Physiology",
issn = "8750-7587",
publisher = "American Physiological Society",
number = "2",

}

TY - JOUR

T1 - Adrenergic airway vascular smooth muscle responsiveness in healthy and asthmatic subjects

AU - Brieva, Jorge

AU - Wanner, Adam

PY - 2001/2/15

Y1 - 2001/2/15

N2 - The purpose of the present study was to determine the responsiveness of airway vascular smooth muscle (AVSM) as assessed by airway mucosal blood flow (Qaw) to inhaled methoxamine (α1-agonist; 0.6-2.3 mg) and albuterol (β2-agonist; 0.2-1.2 mg) in healthy [n = 11; forced expiratory volume in 1 s, 92 ± 4 (SE) % of predicted] and asthmatic (n = 11, mean forced expiratory volume in 1 s, 81 ± 5%) adults. Mean baseline values for Qaw were 43.8 ± 0.7 and 54.3 ± 0.8 μl·min-1·ml-1 of anatomic dead space in healthy and asthmatic subjects, respectively (P < 0.05). After methoxamine inhalation, the maximal mean change in Qaw was -13.5 ± 1.0 μl·min-1·ml-1 in asthmatic and -7.1 ± 2.1 μl·min-1·ml-1 in healthy subjects (P < 0.05). After albuterol, the mean maximal change in Qaw was 3.0 ± 0.8 μl·min-1·ml-1 in asthmatic and 14.0 ± 1.1 μl·min-1·ml-1 in healthy subjects (P < 0.05). These results demonstrate that the contractile response of AVSM to α1-adrenoceptor activation is enhanced and the dilator response of AVSM to β2-adrenoceptor activation is blunted in asthmatic subjects.

AB - The purpose of the present study was to determine the responsiveness of airway vascular smooth muscle (AVSM) as assessed by airway mucosal blood flow (Qaw) to inhaled methoxamine (α1-agonist; 0.6-2.3 mg) and albuterol (β2-agonist; 0.2-1.2 mg) in healthy [n = 11; forced expiratory volume in 1 s, 92 ± 4 (SE) % of predicted] and asthmatic (n = 11, mean forced expiratory volume in 1 s, 81 ± 5%) adults. Mean baseline values for Qaw were 43.8 ± 0.7 and 54.3 ± 0.8 μl·min-1·ml-1 of anatomic dead space in healthy and asthmatic subjects, respectively (P < 0.05). After methoxamine inhalation, the maximal mean change in Qaw was -13.5 ± 1.0 μl·min-1·ml-1 in asthmatic and -7.1 ± 2.1 μl·min-1·ml-1 in healthy subjects (P < 0.05). After albuterol, the mean maximal change in Qaw was 3.0 ± 0.8 μl·min-1·ml-1 in asthmatic and 14.0 ± 1.1 μl·min-1·ml-1 in healthy subjects (P < 0.05). These results demonstrate that the contractile response of AVSM to α1-adrenoceptor activation is enhanced and the dilator response of AVSM to β2-adrenoceptor activation is blunted in asthmatic subjects.

KW - Adrenergic agonists

KW - Asthma

KW - Bronchial blood flow

UR - http://www.scopus.com/inward/record.url?scp=0035146256&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035146256&partnerID=8YFLogxK

M3 - Article

VL - 90

SP - 665

EP - 669

JO - Journal of Applied Physiology

JF - Journal of Applied Physiology

SN - 8750-7587

IS - 2

ER -